PDH recommends Pfizer Booster Dose for Children Ages 12 and Older Following Federal Approval (January 8, 2022)

Following the approval process by the federal government, PDH confirmed that children ages 12 and older are now eligible for a Pfizer COVID-19 vaccine booster dose five months after completing the primary series.  

The five-month booster interval was updated from the previous authorization of six months and is applicable to anyone 12 years of age and older who received the Pfizer BioNTech vaccine for their primary vaccination series.  

The U.S. Food and Drug Administration (FDA) also amended the emergency use authorization for the Pfizer COVID-19 vaccine to allow for a third primary series dose for certain immunocompromised children 5 to 11 years old, at least 28 days following the second dose. 

Children between the ages of 5 and 11 who are fully vaccinated and are not immunocompromised are not eligible for a third dose at this time, but PDH continues to review relevant information and studies from the FDA and CDC. 

“The virus is evolving, and we need to adapt and follow the science to stay ahead of it. The omicron variant appears to be slightly more resistant to the primary series of all approved vaccines,” Acting Secretary of Health Keara Klinepeter said. “While it is important to become fully vaccinated, we need every eligible Pennsylvanian to get their booster dose to maximize protection for you and your loved ones.” 

While anyone 18 years and older may receive any vaccine regardless of which brand of vaccine was received for primary vaccination, those who are 5 to 17 years old are only eligible to receive the Pfizer vaccine. 

Pennsylvania vaccine providers, including pediatricians, primary care physicians, pharmacies, and federally qualified health centers, are able to schedule booster doses and are ready to administer booster appointments now. 

To find a COVID-19 vaccine provider near you, please visit www.vaccines.gov.